Published in Birth Defects Res A Clin Mol Teratol on October 01, 2005
Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev (2010) 2.31
Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet (2008) 1.38
Folic acid and orofacial clefts: a review of the evidence. Oral Dis (2010) 1.33
Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate. Birth Defects Res A Clin Mol Teratol (2008) 1.18
Folic acid in early pregnancy: a public health success story. FASEB J (2010) 1.16
Mechanistic insights into folate supplementation from Crooked tail and other NTD-prone mutant mice. Birth Defects Res A Clin Mol Teratol (2009) 1.14
Characteristics of a spina bifida population including North American Caucasian and Hispanic individuals. Birth Defects Res A Clin Mol Teratol (2008) 1.07
Folate pathway and nonsyndromic cleft lip and palate. Birth Defects Res A Clin Mol Teratol (2010) 1.06
Prevention and schizophrenia--the role of dietary factors. Schizophr Bull (2010) 1.01
Micronutrient fortification of food and its impact on woman and child health: a systematic review. Syst Rev (2013) 0.99
The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders. Front Neurosci (2013) 0.99
The association between race/ethnicity and major birth defects in the United States, 1999-2007. Am J Public Health (2014) 0.98
Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day. Nutrients (2011) 0.98
Biomarkers of Nutrition for Development-Folate Review. J Nutr (2015) 0.98
Neural tube defects, folic acid and methylation. Int J Environ Res Public Health (2013) 0.95
Emerging treatments for retinopathy of prematurity. Semin Ophthalmol (2009) 0.93
Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project. Am J Med Genet A (2013) 0.90
Periconceptional nutrient intakes and risks of neural tube defects in California. Birth Defects Res A Clin Mol Teratol (2010) 0.89
Oral cleft prevention program (OCPP). BMC Pediatr (2012) 0.89
Food fortification and decline in the prevalence of neural tube defects: does public intervention reduce the socioeconomic gap in prevalence? Int J Environ Res Public Health (2013) 0.88
Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice. Am J Clin Nutr (2012) 0.88
CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. BMC Med (2006) 0.85
Neural tube defects and maternal intake of micronutrients related to one-carbon metabolism or antioxidant activity. Birth Defects Res A Clin Mol Teratol (2012) 0.83
Getting to the heart of the matter: epidemiology of cyanotic heart defects. Pediatr Cardiol (2008) 0.83
Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature. Pediatr Surg Int (2010) 0.83
Maternal folate, vitamin B12 and homocysteine levels in pregnancies affected by congenital malformations other than neural tube defects. Birth Defects Res A Clin Mol Teratol (2011) 0.82
Folate and vitamin B12-related genes and risk for omphalocele. Hum Genet (2011) 0.82
Keystone design perforator island flap for closure of myelomeningocele. Childs Nerv Syst (2011) 0.81
Folic acid and prevention of neural tube defects. Can Fam Physician (2008) 0.79
Nonsyndromic cleft lip and palate: CRISPLD genes and the folate gene pathway connection. Birth Defects Res A Clin Mol Teratol (2010) 0.79
A humanized mouse model for the reduced folate carrier. Mol Genet Metab (2007) 0.79
Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice. J Nutr (2013) 0.78
Folic acid and birth malformations. BMJ (2007) 0.77
Spina bifida. Nat Rev Dis Prim (2015) 0.77
Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts. Hum Genet (2015) 0.77
Reduction in non syndromic oral clefts following mandatory flour fortification with folic acid in Northern Iran. Med J Islam Repub Iran (2014) 0.76
Hospital use, associated costs, and payer status for infants born with spina bifida. Birth Defects Res A Clin Mol Teratol (2012) 0.76
Patterns of folic acid use in pregnant Saudi women and prevalence of neural tube defects - Results from a nested case-control study. Prev Med Rep (2015) 0.76
Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele. Birth Defects Res A Clin Mol Teratol (2015) 0.76
Ethnical variations in the incidence of congenital heart defects in gorgan, northern iran: a single-center study. J Tehran Heart Cent (2014) 0.75
Risk factors involved in orofacial cleft predisposition - review. Open Med (Wars) (2015) 0.75
Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S. Am J Prev Med (2016) 0.75
World Birth Defects Day. Towards a national registry for birth defects in Saudi Arabia. Saudi Med J (2015) 0.75
The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects. Front Genet (2015) 0.75
Genetic studies of myelomeningocele. Childs Nerv Syst (2013) 0.75
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol (2006) 4.08
Risk of bacterial meningitis in children with cochlear implants. N Engl J Med (2003) 3.75
Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol (2008) 3.30
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet (2003) 3.00
Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics (2008) 2.88
Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet (2002) 2.70
Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. J Dev Behav Pediatr (2010) 2.69
Survival of "pre-viable" infants in the United States. Wien Klin Wochenschr (2005) 2.68
Racial/ethnic disparities in the identification of children with autism spectrum disorders. Am J Public Health (2008) 2.61
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol (2005) 2.58
A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol (2007) 2.36
Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol (2008) 2.35
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Newborn behavioral and physiological responses to circumcision. MCN Am J Matern Child Nurs (2003) 2.09
Extreme obesity and risk of stillbirth among black and white gravidas. Obstet Gynecol (2007) 2.06
United States head circumference growth reference charts: birth to 21 years. J Pediatr (2010) 2.06
Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol (2013) 2.04
Outcomes of Latina women in CenteringPregnancy group prenatal care compared with individual prenatal care. J Midwifery Womens Health (2013) 2.02
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLoS One (2010) 1.93
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92
Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol (2011) 1.89
Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births. Am J Epidemiol (2009) 1.83
Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. MMWR Surveill Summ (2007) 1.83
Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study. Epilepsia (2005) 1.77
Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab (2010) 1.76
Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med (2011) 1.73
Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics (2006) 1.72
Subcutaneous tissue reapproximation, alone or in combination with drain, in obese women undergoing cesarean delivery. Obstet Gynecol (2005) 1.62
Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation (2006) 1.58
Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol (2009) 1.54
Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep (2015) 1.52
States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. J Womens Health (Larchmt) (2013) 1.49
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol (2011) 1.49
Do differences in accuracy of vital records and hospital discharge data between physician and nurse-midwife attended births matter? Matern Child Health J (2008) 1.44
Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disabil Health J (2009) 1.42
Economic evaluation of a neural tube defect recurrence-prevention program. Am J Prev Med (2008) 1.42
Maternal butalbital use and selected defects in the national birth defects prevention study. Headache (2013) 1.39
Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol (2004) 1.39
Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005. Paediatr Perinat Epidemiol (2014) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet (2012) 1.36
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34
Prevalence of cerebral palsy: Autism and Developmental Disabilities Monitoring Network, three sites, United States, 2004. Disabil Health J (2009) 1.32
Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Indirect estimation of Chlamydia screening coverage using public health surveillance data. Am J Epidemiol (2004) 1.30
A comparison of two surveillance strategies for selected birth defects in Florida. Public Health Rep (2012) 1.30
Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders. J Autism Dev Disord (2011) 1.28
Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study. Hum Reprod (2008) 1.26
Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord (2003) 1.25
Have secular changes in perinatal risk factors contributed to the recent autism prevalence increase? Development and application of a mathematical assessment model. Ann Epidemiol (2011) 1.24
Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol (2003) 1.24
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr (2008) 1.23
Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet (2011) 1.23
Variation by state in outcomes classification for deliveries less than 500 g in the United States. Matern Child Health J (2011) 1.23
Cardiomyopathy and carnitine deficiency. Mol Genet Metab (2008) 1.22
A multilevel analysis of individual, household, and neighborhood correlates of intimate partner violence among low-income pregnant women in Jefferson county, Alabama. Am J Public Health (2009) 1.22
Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med (2010) 1.21
Recurrence of ischemic placental disease. Obstet Gynecol (2007) 1.20
Genetic syndromes among individuals with mental retardation. Am J Med Genet A (2003) 1.18
Multistate study of the epidemiology of clubfoot. Birth Defects Res A Clin Mol Teratol (2009) 1.18
Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res (2009) 1.16
Parent-reported prevalence of autism spectrum disorders in US-born children: an assessment of changes within birth cohorts from the 2003 to the 2007 National Survey of Children's Health. Matern Child Health J (2012) 1.16
Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol (2013) 1.15
Fetal growth risk curves: defining levels of fetal growth restriction by neonatal death risk. Am J Obstet Gynecol (2006) 1.13
Sensitivity of birth certificate reports of birth defects in Atlanta, 1995-2005: effects of maternal, infant, and hospital characteristics. Public Health Rep (2011) 1.13
Mode of delivery and neonatal survival of infants with isolated gastroschisis. Obstet Gynecol (2004) 1.13
Fragile X syndrome detection in newborns-pilot study. Genet Med (2008) 1.12
Effect of population stratification on the identification of significant single-nucleotide polymorphisms in genome-wide association studies. BMC Proc (2009) 1.11
Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol (2013) 1.10
Fortification of flour with folic acid. Food Nutr Bull (2010) 1.09
Randomized controlled trial to improve childhood immunization adherence in rural Pakistan: redesigned immunization card and maternal education. Trop Med Int Health (2010) 1.09
Infantile hypertrophic pyloric stenosis: epidemiology, genetics, and clinical update. Adv Pediatr (2011) 1.08
Accuracy of assisted reproductive technology information on birth certificates: Florida and Massachusetts, 2004-06. Paediatr Perinat Epidemiol (2014) 1.07
Birth defects and environmental exposures: logical, diabolical or the devil is in the details? Environ Res (2012) 1.07
Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs. Birth Defects Res A Clin Mol Teratol (2012) 1.06
The relative contribution of data sources to a birth defects registry utilizing passive multisource ascertainment methods: does a smaller birth defects case ascertainment net lead to overall or disproportionate loss? J Registry Manag (2011) 1.05
Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet Gynecol (2007) 1.05
Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab (2012) 1.02
Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol (2010) 1.02
Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics. Birth Defects Res A Clin Mol Teratol (2007) 1.02
Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salamá, Honduras study. Epilepsia (2011) 1.01
Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics (2013) 1.01